Wild- sequence of MYCN in neuroblastoma cell lines
β Scribed by Michael D. Hogarty; Garrett M. Brodeur
- Publisher
- John Wiley and Sons
- Year
- 1999
- Tongue
- French
- Weight
- 23 KB
- Volume
- 80
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
It has recently been recognized that unbalanced translocations resulting in the gain of material from 17q are the most common chromosomal changes in neuroblastoma. These rearrangements are associated with established indicators of bad prognosis and poor patient survival. We have used 13 fluorescence
A DEAD box gene (DDXI) characterized by a motif with a putative RNA helicase was found at elevated levels, with multiple copies, in a neuroblastorna and in some retinoblastoma cell lines in which the MYCN gene was amplified. The present study was aimed at determining whether amplification o f the DD
Human SK-N-AS neuroblastoma and U-87MG glioblastoma cell lines were found to secrete relatively high levels of glial cell line-derived neurotrophic factor (GDNF). In response to growth factors, cytokines, and pharmacophores, the two cell lines differentially regulated GDNF release. A 24-hr exposure
A candidate murine tumor-suppressor gene, Mom1, has been identified as the secretory phospholipase A2 (GDB nomenclature: PLA2G2A) gene. Evidence suggests that PLA2G2A functions as a tumor-suppressor because mice lacking PLA2G2A expression demonstrate increased colonic polyposis. The human homologue